A Systematic Review of the Role of Monoclonal Antibodies as CGRP Inhibitors in Preventing Chronic and Episodic Migraine

Narmin Hamaamin Hussen, Sara Walid Hamid, Aso Hameed Hasan, Mohammad Amjad Kamal

Open source

DOI
10.2174/0118715273453904261014101910
Published
2026-10-20
Container
CNS & Neurological Disorders - Drug Targets
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0118715273453904261014101910,
  title = {A Systematic Review of the Role of Monoclonal Antibodies as CGRP Inhibitors in Preventing Chronic and Episodic Migraine},
  author = {Narmin Hamaamin Hussen and Sara Walid Hamid and Aso Hameed Hasan and Mohammad Amjad Kamal},
  year = {2026},
  journal = {CNS \& Neurological Disorders - Drug Targets},
  doi = {10.2174/0118715273453904261014101910},
  url = {https://doi.org/10.2174/0118715273453904261014101910}
}

RIS

TY  - JOUR
TI  - A Systematic Review of the Role of Monoclonal Antibodies as CGRP Inhibitors in Preventing Chronic and Episodic Migraine
AU  - Narmin Hamaamin Hussen
AU  - Sara Walid Hamid
AU  - Aso Hameed Hasan
AU  - Mohammad Amjad Kamal
PY  - 2026
JO  - CNS & Neurological Disorders - Drug Targets
DO  - 10.2174/0118715273453904261014101910
UR  - https://doi.org/10.2174/0118715273453904261014101910
ER  - 

APA

Hussen, N. H., Hamid, S. W., Hasan, A. H., & Kamal, M. A. (2026). A Systematic Review of the Role of Monoclonal Antibodies as CGRP Inhibitors in Preventing Chronic and Episodic Migraine. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/0118715273453904261014101910

Source records